Israeli medical devices cloud connectivity and remote care firm BioT has closed a $6.5m seed round.

The company said the money would be used to expand its team, expedite the next generation of the platform and support the growing sales pipeline in the USA and Europe. BioT has also appointed co-founder Daniel Adler as its chief executive officer.

“BioT invites internet of medical things (IoMT) innovators to see how a proven reliable platform can expedite their time to market, reduce dramatically their costs and jump over regulatory barriers, while enabling them to continue and focus on their core expertise,” said Adler. “Our mission with BioT is to accelerate the well-needed vision of providing better treatment for patients wherever they are as if they got it at the best hospitals and clinics in the world.”

Connected care is quickly becoming a major factor in the healthcare industry by eliminating the need for patients to return to a physician’s office for check-ups and monitoring.

BioT says it is poised to disrupt connected care by offering medical device providers a secure, Hipaa and GDPR-compliant cloud platform where they can connect their device, execute algorithms, disseminate alerts and engage with patients and caregivers remotely.

Device providers are spending millions of dollars and years building connected care technology with questionable cyber-security measures that do not excel in patient engagement. With dozens of customers using its technology, BioT offers a low-code platform that reduces the skill-set required to develop such systems. This means IoMT providers can save up to 80% of time and cost to market when compared with creating, building and executing an in-house platform.

The financing round was ed by Bridges Israel, together with North First Ventures and XT Hi-Tech.

“Healthcare must shift from reactive and acute to proactive and preventive,” said Ran Grodecki, managing partner at Bridges Israel. “The only way to achieve this shift is through connected healthcare devices and services that allow ongoing remote monitoring and treatment for patients. We, at Bridges Israel, are happy to join forces with the management team at BioT and with N1V and XT Hi-Tech, our co-investors, to support BioT in developing its platform, improving and shortening time to market and enabling the fulfilment of this connected care vision with the goal of improving the health condition of many.”

BioT is a low-code, easy-to-integrate, cloud-based platform for medical device manufacturers designed to connect patients instantly with caregivers to ensure a seamless continuum of care. The technology is backed by security and regulation liability in a customisable, off-the-shelf product.